iSpecimen ISPC 深 滬
已收盤 11-06 16:00:00 美东时间
0.8142
+0.006
+0.78%
華盛通- 最 高0.8378
- 今 開0.819
- 成交量 23.96万股
- 最 低 0.7851
- 昨 收 0.8079
- 總市值 205.06万
- 52周最高 27.444
- 市盈率 靜 --
- 換手率 9.51%
- 52周最低 0.753
- 委 比 54.23%
- 總股本 251.86万
- 歷史最高 23184.00
- 量 比 0.76
- 振 幅 6.52%
- 歷史最低 0.753
- 每 手 1
- 風險率 6.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多iSpecimen Issues Shares Following Foldlab AI Acquisition
iSpecimen ( ($ISPC) ) has shared an update. On November 2, 2026, iSpecimen comp...
11-06 07:27
iSpecimen Acquires Two AI Products From Foldlab AI For $4.5M
iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace connecting scientists who need biospecimens for medical research with a network of healthcare specimen providers, today announced that it completed, on November 2, 2026, the acquisition of two artificial intell...
11-06 05:38
iSpecimen Stockholders Approve Reverse Stock Split Proposal
iSpecimen ( ($ISPC) ) has shared an announcement. iSpecimen reconvened its spec...
11-03 06:49
iSpecimen shares are trading higher after the company announced next-day healthy donor blood offerings and the development of an AI agent.
iSpecimen shares are trading higher after the company announced next-day healthy donor blood offerings and the development of an AI agent.
10-30 04:36
iSpecimen Shareholders Approve Key Financing and Acquisition Actions
The latest announcement is out from iSpecimen ( ($ISPC) ). On October 9, 2026, ...
10-10 05:02
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
Shares of iSpecimen Inc (NASDAQ:ISPC) rose sharply in pre-market trading after the company announced plans to acquire Foldlab AI assets for $4.5 million, including AI models, software and intellectual property. iSpecimen shares jumped 27.9% to $1.97 in pre-market trading. Here are some other stocks ...
09-08 16:44
iSpecimen to Acquire Foldlab AI Disease Analytics
iSpecimen ( ($ISPC) ) has provided an update. On September 4, 2026, iSpecimen I...
09-05 05:20
iSpecimen Says On August 26, Katharyn Field To Transition From Role As Chief Executive Officer; Shahin Behroyan Appointed As Chief Executive Officer
iSpecimen Says On August 26, Katharyn Field To Transition From Role As Chief Executive Officer; Shahin Behroyan Appointed As Chief Executive Officer
09-01 05:27
iSpecimen Completes Global Cancer Research Project Of Cancer Blood Specimens; Samples Dispatched Within Three Weeks Of Getting Purchase Order
iSpecimen, a provider of human biospecimens, recently completed an international cancer research project involving hundreds of cancer blood specimens, with the samples shipped within three weeks of receiving the purchase order. The project involved the coordination of large-scale biospecimen sourcin...
08-21 04:10
